The cannabis industry’s aggressive advertising and promotion of THC-containing products to young patients has attracted scrutiny from psychiatrists and the Therapeutic Goods Administration (TGA). While some companies face regulatory concerns, others, like Stanley Brothers, argue that their initiatives, such as charitable assistance programs, do not constitute advertising. The industry has seen exponential growth since legalisation in 2016, but concerns persist over off-label prescribing and lack of TGA assessment. Some companies have adopted unconventional marketing tactics, attracting both attention and criticism. The TGA has taken legal action against companies for unauthorised advertising, prompting discussions on the responsible use of medicinal cannabis and the need to prevent exploitation of the system.
Read the full story here
Written by: Angus Thomson and Patrick Begley
Published on May 22, 2024 at 11:34AM
Source: Sydney Morning Herald – Latest News (opens in new tab)